| Authors: |
Radhakrishnan SV; Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Shreveport, Louisiana; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah., Palaniyandi S; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, Feist-Weiller Cancer Center, Shreveport, Louisiana., Mueller G; Division of Hematology and Oncology, University of Regensburg, Regensburg, Germany., Miklos S; Division of Hematology and Oncology, University of Regensburg, Regensburg, Germany., Hager M; Division of Hematology and Oncology, University of Regensburg, Regensburg, Germany., Spacenko E; Division of Hematology and Oncology, University of Regensburg, Regensburg, Germany., Karlsson FJ; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, Feist-Weiller Cancer Center, Shreveport, Louisiana., Huber E; Department of Pathology, University of Regensburg, Regensburg, Germany., Kittan NA; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, Feist-Weiller Cancer Center, Shreveport, Louisiana., Hildebrandt GC; Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, Feist-Weiller Cancer Center, Shreveport, Louisiana. Electronic address: Gerhard.hildebrandt@hci.utah.edu. |